This brand name is authorized in France, Tunisia.
The drug OROKEN contains one active pharmaceutical ingredient (API):
1
|
UNII
97I1C92E55 - CEFIXIME
|
|
Cefixime is an oral third generation cephalosporin which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms. |
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| FR | Base de données publique des médicaments | 60705552, 66907450, 67393849 |
| TN | Direction de la Pharmacie et du Médicament | 2013051, 6113044, 6113045, 9263171, 9263172, 9263173, 9263174 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.